Dr. Jack Cush recaps ACR2025 with suggestions on how to best learn ACR25 content from RheumNow.com and our Videos and podcasts.

NEPTUNUS: Ianalumab in Sjogren's 

Pulmonary hypertension in Sarcoidosis 

Restoring B Cell Compartments with CAR T: Molecular Data is Here

Revised Classification Criteria in axSpA https://www.youtube.com/watch?v=voFJrQo1ANU

NSAID Addition Helps the Spine but not the Hips https://www.youtube.com/watch?v=wTKMC1MTwpE

Sexual Function in axSpA https://www.youtube.com/watch?v=r4_Nsh7e_oo

Coping Strategies in axSpA https://www.youtube.com/watch?v=z9KdNuOu4nI

"ROC-SpA Study" https://www.youtube.com/watch?v=kIEN39XRsSM

Why do patients stay in clinical trials? https://www.youtube.com/watch?v=pVIBoN0jO2o

What to do after first TNR failure in axSpA? https://www.youtube.com/watch?v=PVSyq_Y5-PE

ILD in Patients with Connective Tissue Disease 

Fiber and Methotrexate 

RA ILD Prediction: simple as a dipstick? 

"Leftover Pain in Inflammatory Arthritis" 

From Pain to Wellness in PsA 

Secukinumab vs Ustekinumab in PsA 

Izokibep: still enthused about enthesitis? 

Using Digital Apps to Modify Pain in axSpA

"ROC-SpA Study" 

Secukinumab vs Ustekinumab in PsA 

RA ILD Prediction: simple as a dipstick? 

Sjogren's Disease: PROs as a Filter for Precision Medicine 

Why do patients stay in clinical trials? 

Using Digital Apps to Modify Pain in axSpA 

IgG4: Rare but Treatable! 

From Pain to Wellness in PsA 

IL-2 Therapy in SLE? Maybe 

Sexual Function in axSpA 

"Fact or Fiction: Trinetics Research at ACR" 

CD1/BCMA Dual Targeting: One too many targets in SLE 

Hydroxychloroquine Blood Levels 

The Great Debate: AI in Rheumatology 

Coping Strategies in axSpA 

"What to do After First TNR Failure in axSpA" 

Join panelists Drs. Brian Jaros, Akhil Sood and Michael Putman as they recap highlights from Day 4, the final day of the 2025 ACR Convergence meeting in Chicago.

Join RheumNow Faculty Drs. Shelia Reyes, Mike Putman,  Bella Mehta, and Jack Cush as they discuss highlights and key takeaways from the Day 3 Recap, at the 2025 ACR Convergence meeting in Chicago.